Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S., MRCP UK
Family Physician
MBBS , Diplomate MD , MSC in Family Medicine (Canada) , Diplomate MD (Masters) in Acute Medicine (UK-South Wales) , Diplomate in Aesthetic Medicine, Cert Cosmetiligist & Aesthetician
Family Physician
MBBS , Diplomate MD , MSC in Family Medicine (Canada) , Diplomate MD (Masters) in Acute Medicine (UK-South Wales) , Diplomate in Aesthetic Medicine, Cert Cosmetiligist & Aesthetician
Diabetologist
MBBS, Diploma In Diabetese
Rheumatologist
MBBS, MCPS, MRCGP, DTTMH, MASTMH, MRACGP, Family Medicine Residency Training Certification
Rheumatologist
MBBS, MCPS, MRCGP, DTTMH, MASTMH, MRACGP, Family Medicine Residency Training Certification
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Diabetologist
MBBS, MRCGP , MCPS (Family Medicine)
Internal Medicine Specialist
MBBS, MCPS (Medicine), F.C.P.S.
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), M.C.P.S
Internal Medicine Specialist
MBBS, PLAB (UK), FCPS (Gastroenterology)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures